Vitamin D deficiency is associated with the high risk of colon cancer and a variety of other diseases .
The active vitamin D metabolite 1Î±,25-dihydroxyvitamin D(3) ( 1,25(OH)(2)D(3) ) regulates gene transcription via its nuclear receptor ( VDR ) , and posttranscriptional regulatory mechanisms of gene expression have also been proposed .
We have identified microRNA-22 ( miR-22 ) and several other miRNA species as 1,25(OH)(2)D(3) targets in human colon cancer cells .
Remarkably , miR-22 is induced by 1,25(OH)(2)D(3) in a time- , dose- and VDR-dependent manner .
In SW480-ADH and HCT116 cells , miR-22 loss-of-function by transfection of a miR-22 inhibitor suppresses the antiproliferative effect of 1,25(OH)(2)D(3) .
Additionally , miR-22 inhibition increases cell migration per se and decreases the antimigratory effect of 1,25(OH)(2)D(3) in both cell types .
In silico analysis shows a significant overlap between genes suppressed by 1,25(OH)(2)D(3) and miR-22 putative target genes .
Consistently , miR-22 inhibition abrogates the 1,25(OH)(2)D(3)-mediated suppression of NELL2 , OGN , HNRPH1 , RERE and NFAT5 genes .
In 39 out of 50 ( 78% ) human colon cancer patients , miR-22 expression was found lower in the tumour than in the matched normal tissue and correlated directly with that of VDR .
Our results indicate that miR-22 is induced by 1,25(OH)(2)D(3) in human colon cancer cells and it may contribute to its antitumour action against this neoplasia .
